Estimating the extent of underreporting of mortality among HIV-infected individuals in Rio de Janeiro, Brazil

AIDS Research and Human Retroviruses

Volumn 27, Issue 1, 2011, Pages 25-28

  Pacheco, Antonio G ^a   Saraceni, Valeria ^b   Tuboi, Suely H ^c   Lauria, Lilian M ^b   Moulton, Lawrence H ^d   Faulhaber, José Cláudio ^b   King, Bonnie ^e   Golub, Jonathan E ^f   Durovni, Betina ^b,c   Cavalcante, Solange ^b,g   Harrison, Lee H ^h   Chaisson, Richard E ^f   Schechter, Mauro ^c  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

^b Health Secretariat of Rio de Janeiro City   (Brazil)

^c FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^d JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^e JOHNS HOPKINS UNIVERSITY   (United States)

^f JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g Funda??o Oswaldo Cruz   (Brazil)

^h UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; AGE DISTRIBUTION; ARTICLE; BRAZIL; CAUSE OF DEATH; CD4 LYMPHOCYTE COUNT; COHORT ANALYSIS; DEATH CERTIFICATE; DEMOGRAPHY; DISEASE ASSOCIATION; DISEASE REGISTRY; ETHNIC DIFFERENCE; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; SCHOOL; SEX DIFFERENCE;

ADULT; BRAZIL; CAUSE OF DEATH; CD4 LYMPHOCYTE COUNT; DEATH CERTIFICATES; FEMALE; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; REGISTRIES; RESEARCH DESIGN; RISK FACTORS;

EID: 78651438989     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/aid.2010.0089     Document Type: Article

References (21)

1. Braitstein P, Brinkhof MW, Dabis F, et al.: Mortality of HIV- 1-infected patients in the first year of antiretroviral therapy: Comparison between low-income and high-income countries Lancet 2006;367:817-824.
2. Palella FJ Jr, Delaney KM, Moorman AC, et al.: Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med 1998;338:853-860.
3. Brito AM, Castilho EA, and Szwarcwald CL: Regional patterns of the temporal evolution of the AIDS epidemic in Brazil following the introduction of antiretroviral therapy. Braz J Infect Dis 2005;9:9-19.
4. Marins JR, Jamal LF, Chen SY, et al.: Dramatic improvement in survival among adult Brazilian AIDS patients. AIDS 2003; 17:1675-1682.
5. Pacheco AG, Tuboi SH, Faulhaber JC, Harrison LH, and Schechter M: Increase in non-AIDS related conditions as causes of death among HIV-infected individuals in the HAART era in Brazil. PLoS ONE 2008;3:e1531.
6. Pacheco AG, Tuboi SH, May SB, et al.: Temporal changes in causes of death among HIV-infected patients in the HAART era in Rio de Janeiro, Brazil. J Acquir Immune Defic Syndr 2009;51:624-630.
7. Pacheco AG, Saraceni V, Tuboi S, et al.: Validation of a hierarchical deterministic record linkage algorithm using data from two different cohorts of HIV-infected individuals and mortality databases in Brazil. Am J Epidemiol 2008;168: 1326-1332.
8. 4 counts in HIV-infected Brazilian individuals: A model based on the World Health Organization staging system. J Acquir Immune Defic Syndr 1994;7:163-168.
9. Moulton LH, Golub JE, Durovni B, et al.: Statistical design of THRio: A phased implementation clinic-randomized study of a tuberculosis preventive therapy intervention. Clin Trials 2007;4:190-199.
10. Szwarcwald CL and Castilho EA: [Estimated number of HIV-infected individuals aged 15-49 years in Brazil, 1998]. Cadernos De Saúde Pú blica/Ministério Da Saú de, Fundação Oswaldo Cruz, Escola Nacional De Saúde Pú blica 2000; 16:135-141.
11. WHO: International Statistical Classification of Diseases and Health Related Problems ICD-10, Volume 2: Instruction Manual, 2004.
12. Hosmer DW and Lemeshow S: Applied Logistic Regression. Wiley-Interscience Publication, New York, 2000.
13. R Development Core Team: R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria, 2008.
14. Palella FJ, Jr., Baker RK, Moorman AC, et al.: Mortality in the highly active antiretroviral therapy era: Changing causes of death and disease in the HIV outpatient study. J Acquir Immune Defic Syndr 2006;43:27-34.
15. Lewden C, May T, Rosenthal E, et al.: Changes in causes of death among adults infected by HIV between 2000 and 2005: The "Mortalite 2000 and 2005" surveys (ANRS EN19 and Mortavic). J Acquir Immune Defic Syndr 2008;48:590-598.
16. Sackoff JE, Hanna DB, Pfeiffer MR, and Torian LV: Causes of death among persons with AIDS in the era of highly active antiretroviral therapy: New York City. Ann Intern Med 2006;145:397-406.
17. Mathers CD, Fat DM, Inoue M, Rao C, and Lopez AD: Counting the dead and what they died from: An assessmentof the global status of cause of death data. Bull World Health Organ 2005;83:171-177.
18. Lopman BA, Barnabas RV, Boerma JT, et al.: Creating and validating an algorithm to measure AIDS mortality in the adult population using verbal autopsy. PLoS Med 2006;3: e312.
19. CoDe: Coding Causes of Death in HIV, 2006.
20. Groenewald P, Bradshaw D, Dorrington R, Bourne D, Laubscher R, and Nannan N: Identifying deaths from AIDS in South Africa: An update. AIDS 2005;19:744-745. (Pubitemid 40593086)
21. Centers for Disease Control and Prevention: Electronic record linkage to identify deaths among persons with AIDS- District of Columbia, 2000-2005. MMWR Morb Mortal Wkly Rep 2008;57:631-634.